Derek A. Oldridge
Impact in
- Infectious Diseases top 0.5%
- SARS-CoV-2 and COVID-19 Research
- COVID-19 Clinical Research Studies
- Neurology top 0.5%
- Neuroblastoma Research and Treatments
- Long-Term Effects of COVID-19
Papers in
-
- Cancer Genomics and Diagnostics 7
- Cancer, Hypoxia, and Metabolism 6
- Neurology 13
- Neuroblastoma Research and Treatments 12
- Co-authors
- Sharon J. Diskin (8 shared papers)John M. Maris (8 shared papers)Yuchao Jiang (1 shared paper)Nancy R. Zhang (1 shared paper)Paul J. Zhang (1 shared paper)Chang Su (1 shared paper)Harrison Xiao Bai (1 shared paper)Haiyun Tang (1 shared paper)
- Journals
- Science Immunology (4 papers)Cancer Cell (4 papers)Cell (3 papers)Immunity (3 papers)Cancer Discovery (2 papers)
- Partner nations
- United StatesAustraliaItaly
In The Last Decade
Derek A. Oldridge
47 papers receiving 7.7k citations
Derek A. Oldridge's Hit Papers
Peers
Comparison fields: 5 of 133
- Infectious Diseases 2.9k
- Neurology 1.5k
- Oncology 1.8k
- Immunology 1.5k
- Cancer Research 702
Countries citing papers authored by Derek A. Oldridge
This map shows the geographic impact of Derek A. Oldridge's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Derek A. Oldridge with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Derek A. Oldridge more than expected).
Fields of papers citing papers by Derek A. Oldridge
This network shows the impact of papers produced by Derek A. Oldridge. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Derek A. Oldridge. The network helps show where Derek A. Oldridge may publish in the future.
Co-authors
The 25 scholars most cited alongside Derek A. Oldridge, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 52 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Deep immune profiling of COVID-19 patients reveals distinct immunotypes with therapeutic implications Hit paper breakdown → | 2020 | 1180 |
| 2 | Convergence of Acquired Mutations and Alternative Splicing of CD19 Enables Resistance to CART-19 Immunotherapy Hit paper breakdown → | 2015 | 1068 |
| 3 | mRNA vaccines induce durable immune memory to SARS-CoV-2 and variants of concern Hit paper breakdown → | 2021 | 668 |
| 4 | Distinct antibody and memory B cell responses in SARS-CoV-2 naïve and recovered individuals after mRNA vaccination Hit paper breakdown → | 2021 | 494 |
| 5 | 2015 | 430 | |
| 6 | Rapid induction of antigen-specific CD4+ T cells is associated with coordinated humoral and cellular immunity to SARS-CoV-2 mRNA vaccination Hit paper breakdown → | 2021 | 385 |
| 7 | CD8+ T cells contribute to survival in patients with COVID-19 and hematologic cancer Hit paper breakdown → | 2021 | 377 |
| 8 | Seasonal human coronavirus antibodies are boosted upon SARS-CoV-2 infection but not associated with protection Hit paper breakdown → | 2021 | 300 |
| 9 | 2016 | 295 | |
| 10 | 2015 | 252 | |
| 11 | 2019 | 162 | |
| 12 | 2021 | 159 | |
| 13 | 2022 | 157 | |
| 14 | Mapping the cellular biogeography of human bone marrow niches using single-cell transcriptomics and proteomic imaging Hit paper breakdown → | 2024 | 153 |
| 15 | 2015 | 131 | |
| 16 | 2018 | 118 | |
| 17 | 2015 | 104 | |
| 18 | 2014 | 100 | |
| 19 | 2015 | 95 | |
| 20 | 2021 | 92 |
About Derek A. Oldridge
Derek A. Oldridge is a scholar working on Cancer Research, Neurology, Infectious Diseases, Oncology and Immunology, having authored 52 papers that have together received 7.8k indexed citations. Recurring topics across this work include Neuroblastoma Research and Treatments (12 papers), COVID-19 Clinical Research Studies (9 papers), Cancer Genomics and Diagnostics (7 papers), Cancer, Hypoxia, and Metabolism (6 papers), SARS-CoV-2 and COVID-19 Research (6 papers), Single-cell and spatial transcriptomics (5 papers), CAR-T cell therapy research (4 papers) and Genomic variations and chromosomal abnormalities (4 papers). The work is most often cited by research in Infectious Diseases (2.9k citations), Neurology (1.5k citations), Oncology (1.8k citations), Immunology (1.5k citations) and Cancer Research (702 citations). Derek A. Oldridge has collaborated with scholars based in United States, Australia and Italy. Frequent co-authors include Sharon J. Diskin, John M. Maris, Yuchao Jiang, Nancy R. Zhang, Paul J. Zhang, Chang Su, Harrison Xiao Bai, Haiyun Tang, Weihua Liao and Jian-hua Zhou. Their work appears in journals such as Science Immunology, Cancer Cell, Cell, Immunity and Cancer Discovery.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.